Modification of left ventricular hypertrophy by chronic etomoxir treatment

British Journal of Pharmacology

Volumn 126, Issue 2, 1999, Pages 501-507

  Turcani, Marian ^a,c   Rupp, Heinz ^a,b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c Physics and Informatics   (Slovakia)

Author keywords

CPT 1 inhibitor; Etomoxir; Heart failure; Heart hypertrophy; Myosin isozymes; Pressure overload; Ventricular performance

Indexed keywords

ETOMOXIR; MYOSIN ADENOSINE TRIPHOSPHATASE ISOENZYME;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA CONSTRICTION; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; HEART DILATATION; HEART FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART RIGHT VENTRICLE; HEART VENTRICLE PRESSURE; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PHENOTYPE; PRIORITY JOURNAL; RAT;

ANIMALS; BLOOD PRESSURE; BODY WEIGHT; CARNITINE O-PALMITOYLTRANSFERASE; ENZYME INHIBITORS; EPOXY COMPOUNDS; HEART RATE; HEART VENTRICLES; HYPERTROPHY, LEFT VENTRICULAR; ISOENZYMES; MALE; MYOSINS; ORGAN SIZE; RATS; RATS, WISTAR; VENTRICULAR FUNCTION, LEFT;

EID: 0032927829     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702312     Document Type: Article

References (46)

1. Allard, M.F., Schönekess, B.O., Henning, S.L., English, D.R. & Lopaschuk, G.D. (1994). The contribution of oxidative metabolism and glycolysis to ATP production in hypertrophied heart. Am. J. Physiol., 267, H742-H750.
2. Bergman, G., Atkinson, L., Metcalfe, J., Jackson, N. & Jewitt, D.E. (1980). Beneficial effect of enhanced myocardial carbohydrate utilisation after oxfenicine (L-hydroxyphenylglycine) in angina pectoris. Eur. Heart J., 1, 247-253.
3. Bishop, S.P. & Altschuld, R.A. (1970). Increased glycolytic metabolism in cardiac hypertrophy and congestive heart failure. Am. J. Physiol., 218, 153-159.
4. Brutsaert, D.L. & Sys, S.U. (1989). Relaxation and diastole of the heart. Physiol. Rev., 69, 1228-1315.
5. Christe, M.E. & Rogers, R.L. (1994). Altered glucose and fatty acid oxidation in hearts of the spontaneously hypertensive rat. J. Mol. Cell. Cardiol., 26, 1371-1375.
6. Corr, P.B., Creer, M.H., Yamada, K.A., Saffitz, J.E. & Sobel, B.E. (1989). Prophylaxis of early ventricular fibrillation by inhibition of acylcarnitine accumulation. J. Clin. Invest., 83, 927-936.
7. Eistetter, K. & Wolf, H.P.O. (1986). Etomoxir. Drugs of the Future, 11, 1034-1036.
8. El Alaoui-Talibi, Z., Guendouz, A., Moravec, M. & Moravec, J. (1997). Control of oxidative metabolism in volume-overloaded rat hearts: effects of propionyl-L-carnitine. Am. J. Physiol., 272, H1615-H1624.
9. El Alaoui-Talibi, Z., Landormy, S., Loireau, A., Moravec, J. (1992). Fatty acid oxidation and mechanical performance of volume-overloaded rat hearts. Am. J. Physiol., 262, H1068-H1074.
10. Feldman, A.M., Weinberg, E.O., Ray, P.E. & Lorell, B.H. (1993). Selective changes in cardiac gene expression during compensated hypertrophy and the transition to cardiac decompensation in rats with chronic aortic banding. Circ. Res., 73, 184-192.
11. Ferrari, R., Di Lisa, F., De Jong, J.W., Ceconi, C., Pasini, E., Barbato, R., Menabo, R., Barbieri, M., Carbai, E. & Mugelli, A. (1992). Prolonged propionyl-L-carnitine pretreatment of rabbit: biochemical, hemodynamical and electrophysiological effects on the heart. J. Mol. Cell. Cardiol., 24, 219-232.
12. Hepp, A., Hansis, M., Gülch, R. & Jacob, R. (1974). Left ventricular isovolumetric pressure-volume relations, 'diastolic tone', and contractility in the heart after physical training. Basic Res. Cardiol., 69, 517-531.
13. Higgins, A.J., Morvile, M., Burges, R.A., Gardiner, D.G., Page, M.G. & Blackburn, K.J. (1980). Oxfenicine diverts rat muscle metabolism from fatty acid to carbohydrate oxidation and protects the ischaemic heart. Life Sci., 27, 963-970.
14. Imamura, S.I., Matsuoka, R. & Hiratsuka, E. (1991). Adaptational changes of MHC expression and isozyme transition in cardiac overloading. Am. J. Physiol., 260, H73-H79.
15. Jacob, R., Brändle, M., Dierberger, B. & Ross, C.H. (1990). Conceptional and methodological basis for the evaluation of ventricular and myocardial mechanics. In: Evaluation of cardiac contractility. ed. Jacob R. pp. 75-100. Stuttgart/New York: Gustav Fischer.
16. Kennedy, J.A., Unger, S.A. & Horowitz, J.D. (1996). Inhibition of carnitine palmitoyltransferase-1 in rat heart and liver by perhexiline and amiodarone. Biochem. Pharmacol., 52, 273-280.
17. Lee, S.M., Bahl, J.J. & Bressler, R. (1985). Prevention of the metabolic effects of 2-tetradecylglycidate by octanoic acid in the genetically diabetic mouse (db/db). Biochem. Med., 33, 104-409.
18. Litwin, S.E., Katz, S.E., Weinberg, E.O., Lorell, B.H., Aurigemma, G.P. & Douglas, P.S. (1995). Serial echocardiographic-Doppler assessment of left ventricular geometry and function in rats with pressure-overload hypertrophy. Chronic angiotensin-converting enzyme inhibition attenuates the transition to heart failure. Circulation, 91, 2642-2654.
19. Litwin, S.E., Raya, T.E., Anderson, P.G., Litwin, C.M., Bressler, R. & Goldman, S. (1991). Induction of myocard hypertrophy after coronary ligation in rats decreases ventricular dilatation and improves systolic function. Circulation, 84, 1819-1827.
20. Litwin, S.E., Raya, T.E., Gay, R.G., Bedotto, J.B., Bahl, J.J., Anderson, P.G., Goldman, S. & Bressler, R. (1990). Chronic inhibition of fatty acid oxidation: new model of diastolic dysfunction. Am. J. Physiol., 258, H51-H56.
21. Lopaschuk, G.D., Wall, S.R., Olley, P.M. & Davies, N.J. (1988). Etomoxir, a carnitine palmitoyltransferase I inhibitor, protects hearts from fatty acid-induced ischemic injury independent of changes in long chain acylcarnitine. Circ. Res., 63, 1036-1043.
22. Lullman, H., Lullman-Rauch, R. & Wassermann, O. (1978). Lipidosis induced by amphiphilic cationic drugs. Biochem. Pharmacol., 27, 1103-1108.
23. Massie, B.M., Schaefer, S., Garcia, J., Mckirnan, D., Schwartz, G.G., Wisneski, J.A., Weiner, M.W. & White, F.C. (1995). Myocardial high-energy phosphate and substrate metabolism in swine with moderate left ventricular hypertrophy. Circulation, 91, 1814-1823.
24. Mirsky, I. & Parmley, W.W. (1973). Assessment of passive elastic stiffness for isolated heart muscle and the intact heart. Circ. Res., 33, 233-243.
25. Motterlini, R., Samaja, M., Tarantola, M., Micheletti, R. & Bianchi, G. (1992). Functional and metabolic effects of propionyl-L-carnitine in the isolated perfused hypertrophied rat heart. Mol. Cell. Biochem., 116, 139-145.
26. Pearce, F.J., Forster, J., Deleeuw, G., Williamson, J.R. & Tutwiler, G.F. (1979). Inhibition of fatty acid oxidation in normal and hypoxic perfused rat hearts by 2-tetradecylglycidic acid. J. Mol. Cell. Cardiol., 11, 893-916.
27. Reibel, D.K., Uboh, C.E. & Kent, R.L. (1994). Altered coenzyme A and carnitine metabolism in pressure-overloaded hypertrophied hearts. Am. J. Physiol., 244, H2090-H2097.
28. Rupp, H., Elimban, V. & Dhalla, N.S. (1992a). Modification of subcellular organelles in pressure-overloaded heart by etomoxir, a carnitine palmitoyltransferase I inhibitor. FASEB J., 6, 2349-2353.
29. Rupp, H. & Jacob, R. (1986). Correlation between total catecholamine content and redistribution of myosin isoenzymes in pressure loaded ventricular myocardium of the spontaneously hypertensive rat. Basic Res. Cardiol., 81 (suppl. I). 147-155.
30. Rupp, H. & Jacob, R. (1992). Metabolically-modulated growth and phenotype of the rat heart. Eur. Heart J., 13 (suppl. D). 56-61.
31. Rupp, H., Schulze, W. & Vetter, R. (1995). Dietary medium-chain triglycerides can prevent changes in myosin and SR due to CPT-1 inhibition by etomoxir. Am. J. Physiol., 269, R630-R640.
32. Rupp, H., Wahl, R. & Hansen, M. (1992b). Influence of diet and carnitine palmitoyltransferase I inhibition on myosin and sarcoplasmic reticulum. J. Appl. Physiol., 72, 352-360.
33. Sack, M.N., Rader, T.A., Park, S., Bastin, J., Mccune, S.A. & Kelly, D.P. (1996). Fatty acid oxidation enzyme gene expression is downregulated in the failing heart. Circulation, 94, 2837-2842.
34. Sandler, H. & Dodge, H.T. (1963). Left ventricular tension and stress in man. Circ. Res., 3, 91-104.
35. Schmidt-Schweda, S. & Holubarsch, C. (1997). First clinical trial with etomoxir in patients with chronic heart failure II-III. J. Mol. Cell. Cardiol., 29, A55 (abstract).
36. Schmitz, F.J., Rosen, P. & Reinauer, H. (1995). Improvement of myocardial function and metabolism in diabetic rats by the carnitine palmitoyltransferase inhibitor etomoxir. Horm. Metab. Res., 21, 515-522.
37. Schönekess, B.O., Allard, M.F. & Lopaschuk, G.D. (1995). Propionyl-L-carnitine improvement of hypertrophied heart function is accompanied by an increase in carbohydrate oxidation. Circ. Res., 77, 726-734.
38. Schwartz, K., Carrier, L., Mercadier, J.J., Lompre, A.M. & Boheler, K.R. (1993). Molecular phenotype of the hypertrophied and failing myocardium. Circulation, 87, VII-5-VII-10.
39. Taegtmeyer, H. (1994). Energy metabolism of the heart: from basic concepts to clinical applications. Curr. Probl. Cardiol., 19, 59-113.
40. Turcani, M. & Rupp, H. (1997). Etomoxir improves left ventricular performance of pressure overloaded rat heart. Circulation, 96, 3681-3686.
41. Unger, S.A., Robinson, M.A. & Horowitz, J.D. (1997). Perhexiline improves symptomatic status in elderly patients with severe aortic stenosis. Aust. N.Z.J. Med., 27, 24-28.
42. Vetter, R. & Rupp, H. (1994). CPT-1 inhibition by etomoxir has a chamber-related action on cardiac sarcoplasmic reticulum and isomyosins. Am. J. Physiol., 267, H2091-H2099.
43. Winegrad, S. (1984). Regulation of cardiac contractile proteins; correlations between physiology and biochemistry. Circ. Res., 55, 565-574.
44. Yamada, K.A., Mchowat, J., Yan, G.-X., Donahue, K., Peirick, J., Kleber, A.G. & Corr, P.B. (1994). Cellular uncoupling induced by accumulation of long-chain acylcarnitine during ischemia. Circ. Res., 74, 83-95.
45. Yang, X.P., Samaja, M., English, E., Benatti, P., Tarantola, M., Cardace, G., Motterlini, R., Micheletti, R. & Bianchi, R. (1992). Hemodynamic and metabolic activities of propionyl-L-carnitine in rats with pressure-overload cardiac hypertrophy. J. Cardiovasc. Pharmacol., 20, 88-98.
46. Zarain-Herzberg, A., Rupp, H., Elimban, V. & Dhalla, N.S. (1996). Modification of sarcoplasmic reticulum gene expression in pressure overloaded cardiac hypertrophy by etomoxir. FASEB J., 10, 1303-1309.